| ZUe | isoprenoids d-out qh |
| ST | terpene | |
| terpenoid | ||
| BT | +ZDe organic compounds qh ah |
| ZU2e | isoprene qh |
| ST | 2-methyl-1,3-butadiene | |
| BT | +ZE6.4.6 diene qh ah |
| ZU4e | cannabinoids qh |
| NT | +BE2 cannabinoid of abuse qh ah | |
| +BE2.2e tetrahydrocannabinol qh ah | ||
| BT | +BEe marijuana in any form qh ah | |
| +YW10e hallucinogens qh ah | ||
| RT | BE6 Cannabis qh ah | |
| GD2.6 unspecified AODR mental disorder qh ah |
| ZU4.2 | . cannabidiol qh |
| ZU4.4 | . cannabinol qh |
| ZU6e | monoterpenes qh |
| ZU6.2e | . mecamylamine qh |
| HN | Introduced 2000. | |
| BT | +YP8.8.6 nicotine blockers qh ah | |
| +YV8.2 ganglionic blockaders qh ah | ||
| +ZN2e amines qh ah |
| ZU6.4e | . menthol qh |
| ZU10e | diterpenes qh |
| ZU10.2e | . forskolin qh |
| ZU10.4e | . phorbol qh |
| BT | +YX4e carcinogens qh ah |
| ZU10.4.2e | . . phorbol ester qh |
| BT | +ZK10.2.2 croton oil qh ah |
| ZU10.4.2.2e | . . . phorbol 12,13-dibutyrate qh |
| ZU10.6e | . phytol qh |
| ZU10.8e | . retinoids qh |
| NT | YB10e vitamin A qh ah | |
| YB16e vitamin E qh ah | ||
| YB18e vitamin K qh ah | ||
| BT | +YZ10 pigments and dyes qh ah | |
| +YZ10.2 retinal pigments qh ah | ||
| +ZU14.2e carotenoids qh ah |
| ZU10.8.2e | . . retinol qh |
| ZU10.8.4e | . . retinoic acid qh |
| SN | Retinoic acid is a strong morphogen and a regulator of the ADH-3 allele. ADH is thought to participate in the conversion of retinol (vitamin A) -- a potentially potent teratogen -- to retinoic acid. Since alcohol also use ADH, it may indirectly perturb development by competing for this enzyme. | |
| RT | +ED4.4.2 morphogenesis qh ah | |
| +GJ2.16.2.4e alcohol-related intrauterine disorder qh ah |
| ZU10.8.6e | . . retinaldehyde qh |
| BT | +ZG2e aldehydes qh ah |
| ZU12e | triterpenes qh |
| ZU12.2e | . squalene qh |
| BT | +ZE6.4.8 polyene qh ah | |
| RT | ZV12.2.2.2e lanosterol qh ah | |
| +ZV12.4.2e cholesterol qh ah |
| ZU14e | tetraterpenes qh |
| ZU14.2e | . carotenoids qh |
| NT | +ZU10.8e retinoids qh ah | |
| BT | +YZ10 pigments and dyes qh ah | |
| RT | +YZ10.2 retinal pigments qh ah |
| ZU14.2.2e | . . beta-carotene qh |
| ZVe | steroids d-out qh |
| SN | Naturally occurring or synthetic hormones that affect chemical processes in the body, growth, and sexual and other physiological functions. They include adrenal cortical, testicular, and ovarian
hormones and their derivatives.
In the context of drug use and drug problems, anabolic steroids are of principal concern. These compounds are related to male sex hormones; they increase muscle mass and in women cause masculinization. Athletes misuse anabolic steroids to increase strength and performance. Misuse of adrenal cortical steroids is rare. Steroid misuse is classified in ICD-10 under F55, "abuse of non-dependence producing substances". | |
| NT | +YH4e steroid hormones qh ah | |
| +YH4.2.6e anabolic steroids qh ah | ||
| +ZL4e halogenated steroids qh ah | ||
| BT | +YFe hormones qh ah | |
| +ZDe organic compounds qh ah | ||
| RT | EB14e lipid metabolism qh ah | |
| EB22e hormone metabolism qh ah | ||
| +OZ4.2 AODU to enhance sports performance qh ah | ||
| +TT40.2e athlete qh ah | ||
| YC6.4 steroid isomerases qh ah | ||
| YC14.10.6 steroid hydroxylases qh ah | ||
| +YQ2.4 steroidal anti-inflammatory drugs qh ah |
| ZV2 | steroids by structure qh |
| ZV4e | androstanes qh |
| RT | +YH4.2e androgens qh ah |
| ZV4.2e | . androstanol qh |
| NT | YH4.2.6.2 oxandrolone qh ah | |
| YH4.2.6.4 stanozolol qh ah |
| ZV4.4e | . androstene qh |
| ZV4.4.2e | . . androstenol qh |
| ZV4.4.2.2e | . . . dehydroepiandrosterone qh |
| HN | Introduced 2000. | |
| ST | prasterone | |
| BT | +YJ4.4e neurosteroid GABA A antagonists qh ah |
| ZV4.4.2.4e | . . . androstenedione qh |
| RT | YH4.2.2e testosterone qh ah | |
| YH4.4.2e estradiol qh ah | ||
| +YH4.10e progesterone qh ah |
| ZV6e | estranes qh |
| RT | +YH4.4e estrogens qh ah |
| ZV6.2e | . mifepristone qh |
| HN | Introduced 2000. | |
| ST | RU-486 | |
| BT | +YS2e female contraceptive agents qh ah |
| ZV8e | pregnanes qh |
| ZV8.2e | . pregnadiene qh |
| ZV8.2.2e | . . pregnadienediol qh |
| ZV8.2.2.2e | . . . prednisone qh |
| BT | +YQ2.4 steroidal anti-inflammatory drugs qh ah | |
| +YQ6 antineoplastic agents qh ah |
| ZV8.2.4e | . . pregnadienetriol qh |
| NT | YH4.6.2.2e dexamethasone qh ah |
| ZV8.2.4.2e | . . . prednisolone qh |
| BT | +YQ2.4 steroidal anti-inflammatory drugs qh ah |
| ZV8.4e | . pregnene qh |
| NT | YG34.2.2 spironolactone qh ah |
| ZV8.4.2e | . . cortisone qh |
| ZV8.4.4e | . . pregnenedione qh |
| ZV8.4.4.2e | . . . aldosterone qh |
| RT | +XU4.8.2e adrenal cortex qh ah | |
| +YG34.2 aldosterone antagonists qh ah |
| ZV8.4.4.4e | . . . corticosterone qh |
| NT | +YH4.10e progesterone qh ah | |
| RT | +XU4.8.2e adrenal cortex qh ah |
| ZV10e | cholanes qh |
| RT | +YT10.10e bile acids and salts qh ah |
| ZV10.2e | . cholic acid qh |
| BT | +YT10.10e bile acids and salts qh ah |
| ZV10.2.2e | . . deoxycholic acid qh |
| ZV10.2.2.2e | . . . chenodeoxycholic acid qh |
| BT | +YT10.10e bile acids and salts qh ah |
| ZV10.2.4e | . . taurocholic acid qh |
| BT | +ZJ2.10.8.2.2.2e taurine qh ah |
| ZV12e | cholestanes qh |
| ZV12.2e | . cholestene qh |
| NT | YB14.8 cholecalciferol qh ah | |
| +ZV12.4.2e cholesterol qh ah | ||
| ZV12.4.4.2 sitosterol qh ah |
| ZV12.2.2e | . . cholestadiene qh |
| ZV12.2.2.2e | . . . lanosterol qh |
| RT | ZU12.2e squalene qh ah |
| ZV12.4e | . sterols qh |
| NT | YB14.8 cholecalciferol qh ah | |
| BT | +ZK lipids, fatty acids, fats and oils qh ah |
| ZV12.4.2e | . . cholesterol qh |
| BT | +ZV12.2e cholestene qh ah | |
| RT | ZU12.2e squalene qh ah |
| ZV12.4.2.2 | . . . ketocholesterols qh |
| NT | YB14.2 dihydrotachysterol qh ah | |
| YB14.4 ergocalciferol qh ah |
| ZV12.4.4 | . . phytosterol qh |
| NT | YB14.6 ergosterol qh ah |
| ZV12.4.4.2 | . . . sitosterol qh |
| BT | +ZV12.2e cholestene qh ah |
| ZV14e | lanostane qh |
| ZV16e | cardanolides qh |
| RT | +ZG8.2.6e cardiac glycosides qh ah |
| ZV16.2e | . cardenolide qh |
| NT | +ZG8.2.6.2e strophanthin qh ah |
| ZV20 | steroids by origin qh |
| ZV22e | synthetic steroids qh |
| RT | +YS2e female contraceptive agents qh ah |
| ZV22.2e | . norsteroid qh |
| ZV22.2.2e | . . norpregnane qh |
| ZV22.2.2.2e | . . . norpregnene qh |
| NT | YH4.10.4.2 norgestrel qh ah |
| ZV24e | endogenous steroids qh |
| HN | Introduced 2000. | |
| NT | +YJ4e neurosteroids qh ah |
| ZWe | organometallic compounds d-out qh |
| BT | +ZBe chemical compounds qh ah |
| ZW2 | organomercury compounds qh |
| ZW2.2 | . mercurochrome qh |
| ZW4 | organozinc compounds qh |
| ZXe | coordination compounds d-out qh |
| BT | +ZBe chemical compounds qh ah | |
| RT | +YB12.24e vitamin B12 qh ah | |
| +ZO6.4.10.2e hemoglobin qh ah |
| ZX2e | complex ions qh |
| ZYe | polymers d-out qh |
| BT | +ZBe chemical compounds qh ah |
| ZY2e | natural polymers qh |
| NT | +ZH8.2.4e cellulose qh ah | |
| ZH8.2.4.2e lignin qh ah | ||
| +ZH8.2.6e starches qh ah | ||
| +ZO6e proteins qh ah | ||
| +ZS4e nucleic acids qh ah |
classification thesaurus glossary dictionary definition subject heading list ontology vocabulary knowledge structure knowledge organization terminology concept